{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T23:41:22Z","timestamp":1781134882126,"version":"3.54.1"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"39","license":[{"start":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T00:00:00Z","timestamp":1664496000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,9,30]]},"abstract":"<jats:p>Malignant pleural mesothelioma (MPM) is an aggressive tumor with a poor prognosis. In our study, we aimed to investigate the specific clinical, laboratory, and radiological features of the tumor and the prognostic effect of SUVmax (maximum standardized uptake values) according to PET\/CT (positron emission tomography). Demographic, therapeutic, clinical, and survival information of patients diagnosed with histologically-validated pleural mesothelioma in our hospital between January 2010 to December 2019 will be retrospectively scanned from the hospital records. A total of 116 patients, 61 men (52.6%), and 55 women (47.4%), were analyzed. Thirty five patients (30.2%) were over the age of 65. Percentage of patients over 65 years of age, neutrophil count, and PET SUV Max values, asbestos exposure and pleural thickening rate were significantly higher in the deceased patients\u2019 group than in the living patients\u2019 group (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.042, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.039, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.002, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.004, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.037). T stage (tumor stage), N stage (lymph nodes stage), metastasis stage, and Grade distribution were significantly higher in the deceased patients\u2019 group than in the living patients\u2019 group (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.000, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.000, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.003, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.000). The rates of chemotherapy and surgical treatment, right lung location, and epithelioid pathology were significantly lower in the deceased patients\u2019 group compared to the living patients\u2019 group (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.016, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.030, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.018, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.008). The mean follow-up time was 13 months. Key determinants of survival in MPM include age, male gender, neutrophil increase, pleural thickening, high PET SUV max values, stage, histological type, asbestos exposure, and treatment regimen.<\/jats:p>","DOI":"10.1097\/md.0000000000030711","type":"journal-article","created":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T13:20:45Z","timestamp":1664544045000},"page":"e30711","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Factors affecting the life expectancy in malignant pleural mesothelioma: Our 10 years of studies and experience"],"prefix":"10.1097","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1983-2566","authenticated-orcid":false,"given":"Filiz","family":"Cimen","sequence":"first","affiliation":[{"name":"University of Health Sciences, Atat\u00fcrk Chest Diseases and Thoracic Surgery Education and Research Hospital, Department of Pulmonology, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yetkin","family":"Agackiran","sequence":"additional","affiliation":[{"name":"University of Health Sciences, Atat\u00fcrk Chest Diseases and Thoracic Surgery Education and Research Hospital, Department of Pathology, Ankara, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevim","family":"D\u00fczg\u00fcn","sequence":"additional","affiliation":[{"name":"University of Health Sciences, Atat\u00fcrk Chest Diseases and Thoracic Surgery Education and Research Hospital, Department of Pulmonology, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melike","family":"Aloglu","sequence":"additional","affiliation":[{"name":"University of Health Sciences, Atat\u00fcrk Chest Diseases and Thoracic Surgery Education and Research Hospital, Department of Pulmonology, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayseg\u00fcl","family":"Senturk","sequence":"additional","affiliation":[{"name":"University of Health Sciences, Atat\u00fcrk Chest Diseases and Thoracic Surgery Education and Research Hospital, Department of Pulmonology, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00fckran","family":"Atikcan","sequence":"additional","affiliation":[{"name":"University of Health Sciences, Atat\u00fcrk Chest Diseases and Thoracic Surgery Education and Research Hospital, Department of Pulmonology, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1038\/bjc.2013.504","article-title":"Existing models, but not neutrophil-to-lymphocyte ratio, are prognostic in malignant mesothelioma","volume":"109","author":"Meniawy","year":"2013","journal-title":"Br J Cancer"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1259\/bjr\/55980445","article-title":"Multidetector CT imaging of pleura: comparison of two contrast infusion protocols","volume":"84","author":"Raj","year":"2011","journal-title":"Br J Radiol"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/JTO.0b013e31823f45c1","article-title":"Inflammation-based prognostic indices in malignant pleural mesothelioma","volume":"7","author":"Pinato","year":"2012","journal-title":"J Thorac Oncol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1510\/icvts.2010.255901","article-title":"Does positron emission tomography offer prognostic information in malignant pleural mesothelioma?","volume":"12","author":"Sharif","year":"2011","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ejcts.2007.09.044","article-title":"Malignant pleural mesothelioma: clinicopathologic and survival characteristics in a consecutive series of 394 patients","volume":"33","author":"Borasio","year":"2008","journal-title":"Eur J Cardiothorac Surg"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/thorax.55.9.731","article-title":"Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems","volume":"55","author":"Edwards","year":"2000","journal-title":"Thorax"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1200\/OP.21.00426","article-title":"Management of advanced pleural mesothelioma\u2014at the crossroads","volume":"18","author":"Nowak","year":"2022","journal-title":"J Oncol Pract"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J Clin Oncol"},{"key":"R11-20250504","first-page":"1","article-title":"An update on emerging therapeutic options for malignant pleural mesothelioma","volume":"13","author":"Davis","year":"2022","journal-title":"Lung Cancer: Targets Ther"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jss.2015.01.043","article-title":"Impact of mesothelioma histologic subtype on outcomes in the surveillance, epidemiology, and end results database","volume":"196","author":"Meyerhoff","year":"2015","journal-title":"J Surg Res"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1200\/JCO.2008.19.8523","article-title":"Malignant pleural mesothelioma","volume":"27","author":"Tsao","year":"2009","journal-title":"J Clin Oncol"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.crad.2018.12.010","article-title":"Evaluation of a diagnostic 18F-FDG PET\/CT strategy for differentiating benign from malignant retroperitoneal soft-tissue masses","volume":"74","author":"Lim","year":"2019","journal-title":"Clin Radiol"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1159\/000321370","article-title":"A clinical, radiographic and laboratory evaluation of prognostic factors in 363 patients with malignant pleural mesothelioma","volume":"80","author":"Tanrikulu","year":"2010","journal-title":"Respiration"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"e000506","DOI":"10.1136\/bmjresp-2019-000506","article-title":"\u201cPredicting survival in malignant pleural mesothelioma using routine clinical and laboratory characteristics\u201d","volume":"8","author":"Gunatilake","year":"2021","journal-title":"BMJ Open Respir Res"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1750-1172-3-34","article-title":"Malignant mesothelioma","volume":"3","author":"Moore","year":"2008","journal-title":"Orphanet J Rare Dis"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jtcvs.2006.03.068","article-title":"Positron emission tomography predicts survival in malignant pleural mesothelioma","volume":"132","author":"Flores","year":"2006","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"720768","DOI":"10.1155\/2012\/720768","article-title":"Epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma and pancreatic tumor cell lines: the role of neutrophils and neutrophil-derived elastase","volume":"2012","author":"Grosse-Steffen","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10875-012-9847-0","article-title":"Cancer-related inflammation","volume":"33","author":"Candido","year":"2013","journal-title":"J Clin Immunol"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s00262-004-0525-9","article-title":"Leukocyte orchestration in blood and tumour tissue following interleukin-2 based immunotherapy in metastatic renal cell carcinoma","volume":"53","author":"Donskov","year":"2004","journal-title":"Cancer Immunol Immunother"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"5805","DOI":"10.1158\/1078-0432.CCR-10-2245","article-title":"High blood neutrophil-tolymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy","volume":"16","author":"Kao","year":"2010","journal-title":"Clin Cancer Res"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1097\/JTO.0b013e31826915f1","article-title":"Initial analysis of the international association for the study of lung cancer mesothelioma database","volume":"7","author":"Rusch","year":"2012","journal-title":"J Thorac Oncol"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s13665-013-0045-1","article-title":"Prognostic factors for malignant pleural mesothelioma","volume":"2","author":"Brims","year":"2013","journal-title":"Curr Respir Care Rep"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s13014-015-0575-5","article-title":"Long-term results in malignant pleural mesothelioma treated with neoadjuvant chemotherapy, extrapleural pneumonectomy and intensity-modulated radiotherapy","volume":"10","author":"Thieke","year":"2015","journal-title":"Radiat Oncol"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/bjc.2014.312","article-title":"Prognostic factors in elderly patients with malignant pleural mesothelioma: results of a multicenter survey","volume":"111","author":"Ceresoli","year":"2014","journal-title":"Br J Cancer"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.lungcan.2014.03.006","article-title":"Vinorelbina and gemcitabine as second\u2014or third-line therapy for malignant pleural mesothelioma","volume":"84","author":"Zauderer","year":"2014","journal-title":"Lung Cancer"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.thorsurg.2016.04.003","article-title":"Current treatment of mesothelioma: extrapleural pneumonectomy versus pleurectomy\/decortication","volume":"26","author":"Wolf","year":"2016","journal-title":"Thorac Surg Clin"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/ijc.23874","article-title":"Survival of pleural malignant mesothelioma in Italy: a population-based study","volume":"124","author":"Montanaro","year":"2009","journal-title":"Int J Cancer"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000030711","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T05:15:03Z","timestamp":1746335703000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000030711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,30]]},"references-count":27,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000030711","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,30]]}}}